Administration study as a part of research toward the development of detection method for growth hormone secretagogue GHRP-2 in biological samples
Not Applicable
- Conditions
- o applicable
- Registration Number
- JPRN-jRCT1080220924
- Lead Sponsor
- Anti-Doping Laboratory Mitsubishi Chemical Medience Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Weight: more than 50 kg, BMI: more than 18.5 and under 25
Exclusion Criteria
Hypersensitivity to drugs,
A history of alcoholism or drug addiction,
Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug,
Supplement, grapefruit or its products, or foods containing Hypericum per-foratum consumed within one week before scheduled administration of the study drug, and
Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method